Delivery Order SPE2DB20D3101-SPE2DB22FH8P5
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,821.22, is for the delivery of LUMIGAN 0.01% eye drops in 5ml bottles. The award is a Firm Fixed Price Delivery Order with a completion date of June 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite...
- This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, 5ml, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $1,051.44 and a completion date of January 30, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp holds an...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,592.84, is for the delivery of LUMIGAN 0.01% eye drops in 5ml vials. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,190.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product. The contract has an ultimate completion date of May 15, 2023 and is structured as a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.74 firm fixed-price delivery order is for the supply of LUMIGAN 0.01% eye drops, a prescription medication. The contract has a completion date of February 22, 2023 and was awarded on February 21, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, with a ceiling value of $3,635.40. The contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of April 10, 2025. This contract award is not associated with a set-aside designation, indicating...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,495.92, for the delivery of LUMIGAN 0.01% Eye Drops 5ML. The award has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,741.16, is for the supply of LUMIGAN 0.01% eye drops in 5 ML containers. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,457.37, was made to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 21, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of LUMIGAN 0.01% eye drops (5ml) to the Defense Logistics Agency (DLA). The $1,084.74 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 21, 2021. The contract has an ultimate completion date of December 22, 2021 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FH8P5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,353.39, is for the delivery of LUMIGAN 0.01% eye drops in 5 milliliter packaging. The contract is a Firm Fixed Price Delivery Order with a completion date of February 18, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for up to $999,999,999.00 to provide a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation for up to $750,000 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/17/22 |